Oncology Research

Sarah Cannon Research Institute is the research arm of HCA Healthcare’s global cancer institute, Sarah Cannon. Focused on advancing therapies for patients, it is one of the world’s leading clinical research organizations conducting community-based clinical trials throughout the United States and United Kingdom. Sarah Cannon’s network of strategic sites includes more than 275 physicians who engage in research. The organization has led more than 500+ first-in-man clinical trials since its inception in 1993, and has been a clinical trial leader in the majority of approved cancer therapies over the last 10 years.

Participation in a clinical trial is the first step in fighting cancer, not the last.®

Fighting Cancer Together

Collectively, our comprehensive patient-centric services across the network ensure that we are fulfilling our mission to advance science and transform care. If you want to learn more about Sarah Cannon, have a question about cancer or simply need guidance through diagnosis, visit askSARAH and connect with a compassionate care provider.